SAF2006-07523; BFU2009-10109, Redes temáticas de Investigación Cooperativa en salud (ISCIII y FEDER): RD06/0001/1013; GRUPOS UCM-BSCH (951579) and Plan Nacional sobre Drogas (SAS/125/2009)
Marco, E.M., Viveros, M.P. (2009). The critical role of the endocannabinoid system in emotional homeostasis: avoiding excess and deficiencies. Mini Rev. Med. Chem. 9, 1407-15.
Mateos, B., Borcel, E., Loriga, R., Luesu, W., Bini, V., Llorente, R., Castelli, M., Viveros, M.P. Adolescent exposure to nicotine and/or the cannabinoid agonist CP 55,940 induces gender-dependent long-lasting memory impairments and changes in brain nicotinic and CB1 cannabinoid receptors (2011). J Psychopharmacol. 25, 1676-90
Rey, A.A., Purrio, M-, Viveros, M.P., Lutz, B. Biphasic effects of cannabinoids in anxiety responses: CB1 and GABA(B) receptors in the balance of GABAergic and glutamatergic neurotransmission (2012). Neuropsychopharmacology 37, 2624-34.
Suárez, J., Rivera, P., Llorente, R., Romero-Zerbo, S.Y., Bermúdez-Silva, F.J., de Fonseca, F.R., Viveros, M.P. (2010). Early maternal deprivation induces changes on the expression of 2-AG biosynthesis and degradation enzymes in neonatal rat hippocampus. Brain Res. 1349, 162-73.
Viveros, M.P., Llorente, R., Suarez, J., Llorente-Berzal, A., López-Gallardo, M., de Fonseca, F.R. (2012) The endocannabinoid system in critical neurodevelopmental periods: sex differences and neuropsychiatric implications. J Psychopharmacol. 26,164-76.
Viveros, M.P., Marco, E.M., File, S.E. (2005) Endocannabinoid system and stress and anxiety responses. Pharmacol. Biochem. Behav. 81, 331-42.